Filing Details
- Accession Number:
- 0001209191-21-034571
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-20 18:19:00
- Reporting Period:
- 2021-05-18
- Accepted Time:
- 2021-05-20 18:19:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808158 | Repare Therapeutics Inc. | RPTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1477123 | Mitchell Lloyd Segal | C/O Repare Therapeutics Inc. 7210 Frederick-Banting, Suite 100 St-Laurent A8 H4S 2A1 | President And Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-18 | 1,800 | $35.00 | 141,154 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Disposition | 2021-05-19 | 3,800 | $35.06 | 137,354 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
- These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.25, inclusive.
Billionaire Hedge Funds
